BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Erstad DJ, Tanabe KK. Hepatocellular carcinoma: early-stage management challenges. J Hepatocell Carcinoma 2017;4:81-92. [PMID: 28721349 DOI: 10.2147/JHC.S107370] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Chen F, Wu Y, Xu H, Song T, Yan S. Impact of marital status on overall survival in patients with early-stage hepatocellular carcinoma. Sci Rep 2022;12:19923. [DOI: 10.1038/s41598-022-14120-1] [Reference Citation Analysis]
2 Zhang Y, Qin Y, Dong P, Ning H, Wang G. Liver resection, radiofrequency ablation, and radiofrequency ablation combined with transcatheter arterial chemoembolization for very-early- and early-stage hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis for comparison of efficacy. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.991944] [Reference Citation Analysis]
3 Liao YL, Wang TJ, Su CW, Liang SY, Liu CY, Fan JY. Efficacy of a Decision Support Intervention on Decisional Conflict Related to Hepatocellular Cancer Treatment: A Randomized Controlled Trial. Clin Nurs Res 2022;:10547738221121447. [PMID: 36082423 DOI: 10.1177/10547738221121447] [Reference Citation Analysis]
4 Papageorge MV, de Geus SWL, Woods AP, Ng SC, Lee S, McAneny D, Tseng JF, Kenzik KM, Sachs TE. Surveillance Patterns for Hepatocellular Carcinoma among Screening-Eligible Patients in the Medicare Population. Ann Surg Oncol 2022. [PMID: 36057903 DOI: 10.1245/s10434-022-12360-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cao M, Li H, Sun D, He S, Yang F, Yan X, Zhang S, Zha Z, Zhou J, Luo P, Gong J, Ma H, Zhang S, Sun X, Xia C, Peng J, Chen W. Assessment of the compliance, influencing factors, and yielding results of liver cancer screening in a high-risk population: A cross-sectional study. Cancer 2022. [PMID: 35996957 DOI: 10.1002/cncr.34418] [Reference Citation Analysis]
6 Fernandes DA, Dal Lago EA, Oliver FA, Loureiro BMC, Martins DL, Penachim TJ, Barros RHO, Araújo Filho JAB, Eloy da Costa LB, da Silva ÁMO, de Ataíde EC, Boin IFSF, Caserta NMG. Hepatobiliary phases in magnetic resonance imaging using liver-specific contrast for focal lesions in clinical practice. World J Hepatol 2022; 14(7): 1459-1469 [DOI: 10.4254/wjh.v14.i7.1459] [Reference Citation Analysis]
7 Zhang G, Wang Y, Fuchs BC, Guo W, Drum DL, Erstad DJ, Shi B, Deleo AB, Zheng H, Cai L, Zhang L, Tanabe KK, Wang X. Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram. Front Oncol 2022;12:913736. [DOI: 10.3389/fonc.2022.913736] [Reference Citation Analysis]
8 Wang L, Ma X, Feng B, Wang S, Liang M, Li D, Wang S, Zhao X. Multi-Sequence MR-Based Radiomics Signature for Predicting Early Recurrence in Solitary Hepatocellular Carcinoma ≤5 cm. Front Oncol 2022;12:899404. [PMID: 35756618 DOI: 10.3389/fonc.2022.899404] [Reference Citation Analysis]
9 Wang Y, Li W, Man W, Dong X, Luo Y, Zhang Y, Zhang Y, Dong C, Sun W, Yang P, Ahmad S. Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma. Computational Intelligence and Neuroscience 2022;2022:1-10. [DOI: 10.1155/2022/9783113] [Reference Citation Analysis]
10 Wang X, Mao L, Li C, Hui Y, Yu Z, Sun M, Li Y, Guo G, Yang W, Cui B, Fan X, Sun C. The potential role of FNDC5/irisin in various liver diseases: awakening the sleeping beauties. Expert Rev Mol Med 2022;24:e23. [PMID: 35695040 DOI: 10.1017/erm.2022.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hui Y, Cui B, Wang X, Sun M, Li Y, Yang W, Guo G, Mao L, Yu Z, Fan X, Sun C. Sarcopenic obesity in liver disease: Handling both sides of the penny. Portal Hypertension & Cirrhosis 2022;1:42-56. [DOI: 10.1002/poh2.10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Shen Y, Xu Y, Wei J, Li W. The Prognostic Role of Circulating FPR Before Operation in Patients with BCLC A-C Hepatocellular Carcinoma: A Retrospective Cohort Study. JHC 2022;Volume 9:467-76. [DOI: 10.2147/jhc.s369168] [Reference Citation Analysis]
13 Keshavarz P, Raman SS. Comparison of combined transarterial chemoembolization and ablations in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Abdom Radiol (NY) 2022;47:1009-23. [PMID: 34982183 DOI: 10.1007/s00261-021-03368-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kang Y, Cai Y, Yang Y. The gut microbiome and hepatocellular carcinoma: Implications for early diagnostic biomarkers and novel therapies. Liver Cancer. [DOI: 10.1159/000521358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
15 Liu G, Ouyang X, Gong L, Yao L, Liu S, Li J, Zhang Q, Xiao Y. E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B. Mol Ther Nucleic Acids 2021;26:104-13. [PMID: 34513297 DOI: 10.1016/j.omtn.2021.07.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Karanam G, Arumugam MK. Potential anticancer effects of cyclo(-Pro-Tyr) against N-diethyl nitrosamine induced hepatocellular carcinoma in mouse through PI3K/AKT signaling. Environ Toxicol 2021. [PMID: 34726822 DOI: 10.1002/tox.23395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang YC, Tian ZB, Tang XQ. Bioinformatics screening of biomarkers related to liver cancer. BMC Bioinformatics 2021;22:521. [PMID: 34696748 DOI: 10.1186/s12859-021-04411-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Lv X, Chen M, Kong C, Shu G, Meng M, Ye W, Cheng S, Zheng L, Fang S, Chen C, Wu F, Weng Q, Tu J, Zhao Z, Ji J. Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablation. Eur J Radiol 2021;144:109955. [PMID: 34600237 DOI: 10.1016/j.ejrad.2021.109955] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Martini G, Ciardiello D, Paragliola F, Nacca V, Santaniello W, Urraro F, Stanzione M, Niosi M, Dallio M, Federico A, Selvaggi F, Della Corte CM, Napolitano S, Ciardiello F, Martinelli E. How Immunotherapy Has Changed the Continuum of Care in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4719. [PMID: 34572944 DOI: 10.3390/cancers13184719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Sulaiman AS, Gani RA, Hasan I, Lesmana CRA, Kurniawan J, Jasirwan COM, Kalista KF, Nababan SHH, Aprilicia G, Lesmana LA. Overall Survival of Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation (RFA) Treatment: a Retrospective Cohort Study from Two Referral Hospitals in Indonesia. J Gastrointest Cancer 2021. [PMID: 34379264 DOI: 10.1007/s12029-021-00676-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Wu J, Zhang T, Chen Y, Ha S. MiR-139-5p influences hepatocellular carcinoma cell invasion and proliferation capacities via decreasing SLITRK4 expression. Biosci Rep 2020;40:BSR20193295. [PMID: 32285917 DOI: 10.1042/BSR20193295] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
22 Jiang C, Cheng G, Liao M, Huang J. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis. World J Surg Oncol 2021;19:81. [PMID: 33741001 DOI: 10.1186/s12957-021-02188-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
23 Han J, Bai Y, Wang J, Xie XL, Li AD, Ding Q, Cui ZJ, Yin J, Jiang XY, Jiang HQ. REC8 promotes tumor migration, invasion and angiogenesis by targeting the PKA pathway in hepatocellular carcinoma. Clin Exp Med 2021;21:479-92. [PMID: 33677646 DOI: 10.1007/s10238-021-00698-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
24 Wang C, Wang S, Lei X, Zang M. CC Chemokine Ligand 17 Promoted Cell Metastasis via Tumor Necrosis Factor α /Nuclear Factor Kappa-B Signaling Pathway. j biomater tissue eng 2021;11:302-7. [DOI: 10.1166/jbt.2021.2540] [Reference Citation Analysis]
25 Zhang C, Yang M, Ericsson AC. The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer. Front Oncol 2020;10:524205. [PMID: 33163393 DOI: 10.3389/fonc.2020.524205] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
26 Kim C, Cigarroa N, Surabhi V, Ganeshan B, Pillai AK. Retrospective CT/MRI Texture Analysis of Rapidly Progressive Hepatocellular Carcinoma. J Pers Med 2020;10:E136. [PMID: 32967100 DOI: 10.3390/jpm10030136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Ouyang G, Pan G, Wu Y, Liu Q, Lu W, Chen X. Prognostic Significance of Preoperative Gamma-Glutamyltransferase to Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients with Curative Liver Resection: A Retrospective Cohort Study. Cancer Manag Res 2020;12:8721-32. [PMID: 33061570 DOI: 10.2147/CMAR.S263370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Cho HJ, Baek GO, Seo CW, Ahn HR, Sung S, Son JA, Kim SS, Cho SW, Jang JW, Nam SW, Cheong JY, Eun JW. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma. Cancer Med 2020;9:5459-72. [PMID: 32537885 DOI: 10.1002/cam4.3230] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
29 Moon CM, Shin SS, Heo SH, Jeong YY. Metabolic Alterations Associated with Early-Stage Hepatocellular Carcinoma and Their Correlation with Aging and Enzymatic Activity in Patients with Viral Hepatitis-Induced Liver Cirrhosis: A Preliminary Study. J Clin Med 2020;9:E765. [PMID: 32178316 DOI: 10.3390/jcm9030765] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Liao Y, Wang T, Yang T. Development and Validation of a Tool to Assess Hepatocellular Carcinoma Knowledge among Hepatocellular Carcinoma Patients in Taiwan. OJN 2020;10:341-352. [DOI: 10.4236/ojn.2020.104023] [Reference Citation Analysis]
31 Nagai K, Uranbileg B, Chen Z, Fujioka A, Yamazaki T, Matsumoto Y, Tsukamoto H, Ikeda H, Yatomi Y, Chiba H, Hui SP, Nakazawa T, Saito R, Koshiba S, Aoki J, Saigusa D, Tomioka Y. Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging. Rapid Commun Mass Spectrom. 2020;34 Suppl 1:e8551. [PMID: 31412144 DOI: 10.1002/rcm.8551] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
32 Liu Y, Zhao JJ, Zhou ZQ, Pan QZ, Zhu Q, Tang Y, Xia JC, Weng DS. IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma. Cancer Manag Res 2019;11:6691-702. [PMID: 31410060 DOI: 10.2147/CMAR.S200627] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
33 DiStefano JK, Davis B. Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma. Cancers (Basel). 2019;11. [PMID: 30959792 DOI: 10.3390/cancers11040486] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 13.7] [Reference Citation Analysis]
34 Cheng Y, Luo L, Zhang J, Zhou M, Tang Y, He G, Lu Y, Wang Z, Pan M. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma. J Gastrointest Surg 2019;23:2354-61. [PMID: 30805878 DOI: 10.1007/s11605-018-04067-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
35 Nazarnezhad M, Moosavy SH, Davoodian P, Eftekhar E, Nejatizadeh A, Azad M. The demographic and paraclinical characteristics of patients with hepatitis B presenting to Shahid Mohammadi Hospital and Clinic and other private clinics in Bandar Abbas, Iran. J Adv Pharm Technol Res 2018;9:139-46. [PMID: 30637232 DOI: 10.4103/japtr.JAPTR_328_18] [Reference Citation Analysis]
36 Tian Z, Tang X. Identification of Candidate Biomarkers and Pathways Associated with Liver Cancer by Bioinformatics Analysis. Intelligent Computing Theories and Application 2019. [DOI: 10.1007/978-3-030-26969-2_52] [Reference Citation Analysis]
37 Wu Y, Ren F, Chai Y, Xue Z, Shen C, Zhang X, Lv Y, Hu L. Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection. Oncol Lett 2019;17:165-74. [PMID: 30655752 DOI: 10.3892/ol.2018.9618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
38 Li Q, Wang W, Hu YC, Yin TT, He J. Knockdown of Ubiquitin Associated Protein 2-Like (UBAP2L) Inhibits Growth and Metastasis of Hepatocellular Carcinoma. Med Sci Monit. 2018;24:7109-7118. [PMID: 30291221 DOI: 10.12659/msm.912861] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
39 Jing R, Zhou X, Zhao J, Wei Y, Zuo B, You A, Rao Q, Gao X, Yang R, Chen L, Lu Z, Zhou Q, Zhang N, Yin H. Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and humans in vitro. Hepatology 2018;68:1391-411. [PMID: 29405333 DOI: 10.1002/hep.29829] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
40 Solmaz Avcıkurt A, Altun E. Oral antidiyabetik metforminin hepatosellüler kanser hücreleri üzerine etkisi. Cukurova Medical Journal 2018;43:557-561. [DOI: 10.17826/cumj.341138] [Reference Citation Analysis]
41 Wu T, Yao Y, Sun R, Wang H, Yin X, Zhang J, Zhou Q, Huangfu C. Arterial Infusion of Rapamycin in the Treatment of Rabbit Hepatocellular Carcinoma to Improve the Effect of TACE. Open Life Sci 2018;13:299-304. [PMID: 33817096 DOI: 10.1515/biol-2018-0036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Wang W, Zhang M, Peng Y, He J. Ubiquitin Associated Protein 2-Like (UBAP2L) Overexpression in Patients with Hepatocellular Carcinoma and its Clinical Significance. Med Sci Monit 2017;23:4779-88. [PMID: 28981479 DOI: 10.12659/msm.907071] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]